Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer

Table 1

Associations between CDCP1 expression status and clinic-pathological characteristics in BrCa.

Clinic-pathological characteristics		Case	CDCP1 expression		χ^2 value	Value
			Low	High
Age	≤50	58	37	21	5.790	0.016
	>50	60	25	35
	NA	1
Differentiation	I (I–II)	40	20	20	0.107	0.744
	II&III	79	42	37
T stage^∗	T1	25	10	15	—	0.281
	T2	81	43	38
	T3	12	8	4
	NA	1
N stage^∗	N0	43	17	26	—	0.044
	N1	36	21	15
	N2	28	16	12
	N3	8	7	1
	NA	4
TNM stage^∗	1	7	3	4	—	0.224
	2	69	33	36
	3	39	25	14
	NA	4
ER status	Negative	43	15	28	8.460	0.004
	Positive	75	47	28
	NA	1
PR status	Negative	51	18	33	11.367	0.001
	Positive	66	44	22
	NA	2
HER2 status	Negative	91	45	46	1.089	0.297
	Positive	28	17	11
Molecular type	Luminal	78	50	28	12.439	0.002
	HER2+	15	5	10
	TNBC	25	7	18
	NA	1
Survival status	Alive	80	48	32	5.541	0.019
	Dead	38	14	24
	NA	1

Note. ^∗ Checked using the corrected chi-square test.